NCT04330716

Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers

Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers - GeneBOPP

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 269 (actual)
• Sponsor: Dana-Farber Cancer Institute · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This study is evaluating the effect of two pre-test education methods on participants interested in genetic testing for hereditary cancer risk.

Detailed description

This prospective, randomized controlled trial will evaluate the effect of two pre-test education methods on the level of participation in genetic testing for hereditary cancer risk. A prospective study examines outcomes before the development of a disease. * The research study procedures include screening for eligibility, randomization and a series of questionnaires. * Participants will be randomized, or assigned by chance, to one of two methods of pre-genetic test education and after completing either pre-test education participants will be offered the opportunity to have genetic testing performed Two methods of pre-genetic test education: * video education * in-person counseling * Genetic testing will be performed by blood draw. * It is expected that 500 people will participate in this study * Participants will be in the research study for up to 5 yrs after enrollment

Conditions

• Breast Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Metastatic Prostate Cancer

Interventions

Type	Name	Description
BEHAVIORAL	Standard Genetic Counseling	Standard of care genetic counseling
BEHAVIORAL	Educational Video	Video tutorial about genetic testing

Timeline

• Start date: 2020-12-01
• Primary completion: 2023-12-31
• Completion: 2023-12-31
• First posted: 2020-04-01
• Last updated: 2024-01-19

Locations

6 sites across 1 country: United States